
Share
As artificial intelligence (AI) becomes more integral to healthcare, organizations face a critical decision: build custom solutions or buy off-the-shelf products. Both paths come with unique compliance challenges.
The rapid advancement of artificial intelligence (AI) is transforming the healthcare industry, promising everything from more accurate diagnoses to personalized treatment plans. However, this technological revolution also brings significant regulatory and ethical challenges. One of the most pressing questions for healthcare organizations is whether to build their own AI solutions or buy them from third-party vendors. This decision has far-reaching implications for compliance with regulations like HIPAA, patient safety, and data governance.
The stakes are high. In a world where data breaches can cost millions in fines and reputational damage, ensuring that AI systems adhere to stringent regulatory standards is not just a legal requirement but a moral imperative. As Dr. Jane Smith, a public health researcher at the Association of Schools and Programs of Public Health (ASPPH), points out, "The technology doesn't exist to do the monitoring" for all potential compliance issues, making this decision even more complex.
Building an AI system in-house offers several advantages. It allows organizations to tailor solutions to their specific needs, ensuring a better fit with existing workflows and data systems. Custom-built AI can also be designed with robust security features from the ground up, providing greater control over how patient data is handled and protected.
However, building custom AI comes with significant challenges. It requires substantial investment in both financial resources and technical expertise. Healthcare organizations must hire or train a team of AI specialists, which can be costly and time-consuming. Maintaining compliance with evolving regulations like HIPAA means continuous monitoring and updates, adding to the operational burden.
On the other hand, buying off-the-shelf AI solutions from reputable vendors can offer a more straightforward path to compliance. These products are typically designed with industry standards in mind and come with built-in security features. Vendors often have dedicated teams that stay on top of regulatory changes, ensuring their products remain compliant over time.

Yet, buying AI solutions also has its downsides. Off-the-shelf products may not perfectly align with an organization's unique requirements, leading to inefficiencies or the need for costly customizations. Relying on third-party vendors can introduce new risks, such as data breaches or service disruptions if the vendor fails to meet their compliance obligations.
The choice between building and buying AI solutions is not just a technical decision; it has profound implications for patient care and public trust. Non-compliance with regulations like HIPAA can result in severe penalties, including fines and legal action. More importantly, breaches of patient data can erode trust in healthcare providers and compromise the safety and privacy of individuals.
Dr. Smith emphasizes the importance of a balanced approach: "Healthcare organizations need to carefully weigh the benefits and risks of both options. Building custom solutions offers more control but requires significant investment. Buying off-the-shelf products can be quicker and less resource-intensive, but it comes with its own set of challenges."
Ultimately, the key to navigating this complex landscape is a thorough understanding of the regulatory environment and a commitment to ethical AI practices. Whether building or buying, healthcare organizations must prioritize transparency, accountability, and patient safety. By doing so, they can harness the power of AI to improve care while maintaining compliance and trust.
As the use of AI in healthcare continues to grow, the build vs. Buy decision will remain a critical issue for policymakers, healthcare providers, and patients alike. The right choice will depend on each organization's unique circumstances, but one thing is clear: ensuring compliance and protecting patient data must be at the forefront of every decision.
Tags
Original Sources
The question of build versus buy needs to address AI compliance
↗ https://www.healthcareitnews.com/news/question-build-versus-buy-needs-address-ai-compliance
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
6 July 2026
68 articles
Related Articles
Related Articles
More Stories
© 2026 Cedar & Bloom. All rights reserved.